Skip to main content
Anthem Biosciences Limited logo

Anthem Biosciences Limited — Investor Relations & Filings

Ticker · ANTHEM ISIN · INE0CZ201020 LEI · 335800FNA941U9NMD221 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 84 across all filing types
Latest filing 2026-04-22 Board/Management Inform…
Country IN India
Listing BSE.NS ANTHEM

About Anthem Biosciences Limited

https://anthembio.com/

Anthem Biosciences Limited is a comprehensive Contract Research and Manufacturing Services (CRAMS) organization providing integrated solutions across the drug discovery and development lifecycle. The company offers services including medicinal chemistry, process research, analytical validation, and large-scale commercial manufacturing. Its technical expertise spans synthetic organic chemistry, fermentation technology, molecular biology, and cell biology, enabling the production of both small molecules and biologics. Anthem serves global clients in the pharmaceutical, biopharmaceutical, and specialty chemical sectors. The organization features state-of-the-art research facilities and cGMP-compliant manufacturing units, facilitating a seamless transition from initial concept to market-ready products. Its commitment to intellectual property protection and rigorous quality management systems underpins its collaborative partnerships.

Recent filings

Filing Released Lang Actions
Updates
Board/Management Information Classification · 95% confidence The document is an official intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the appointment of new statutory auditors for the company, effective from the conclusion of the upcoming Annual General Meeting (AGM) in the financial year 2026-2027. The document includes details about the outgoing and incoming auditors, their terms, and a brief profile of the new auditor firm. It also discusses approval of an Upside Sharing Arrangement related to shareholder agreements. The content is primarily an announcement of board decisions and changes in auditors, not the audit report itself or a full annual report. The document is regulatory in nature, informing stock exchanges and shareholders about board decisions and compliance with SEBI regulations. Therefore, it fits best under "Board/Management Information (MANG)" as it relates to changes in company management/audit appointments and disclosures required by regulators.
2026-04-22 English
Change in Auditors
Board/Management Information Classification · 95% confidence The document is an official intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the appointment of new statutory auditors for the company, effective from the conclusion of the upcoming Annual General Meeting (AGM) in the financial year 2026-2027. The document includes details about the outgoing and incoming auditors, their terms, and a brief profile of the new auditor firm. It also discusses approval of an Upside Sharing Arrangement related to shareholder agreements. The document is a formal announcement of board decisions and approvals, not a full audit report or annual report. It does not contain financial statements or audit results but rather informs stakeholders about changes in auditors and corporate arrangements. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related governance decisions. The document length and detail support this classification, and it is not merely a short notice or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA).
2026-04-22 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. It is addressed to stock exchanges and certifies that details of securities dematerialized/rematerialized have been furnished to the exchanges. The document is a compliance certificate from the Registrar and Transfer Agent, not a financial report or announcement of financial results. It is also relatively short (3192 characters) and serves as an official attestation rather than a report or announcement of voting results or capital changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents and certifications that do not fit other specific categories.
2026-04-06 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the closure of the trading window for insiders ahead of the board meeting to approve financial results. It references SEBI regulations on insider trading and informs about the trading restrictions period. The document does not contain any financial data, results, or detailed report content. It is a regulatory announcement related to compliance and insider trading rules, not a financial report or earnings release. The document length is short (1470 characters), and it serves as an official intimation to the exchanges. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2026-03-27 English
Resignation
Board/Management Information Classification · 100% confidence The document is a formal disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, announcing the resignation of a senior management personnel, Mr. K. Ramakrishnan, General Counsel of the company. It includes details about the resignation date and the person's role in senior management. There are no financial statements, earnings data, or report attachments. The content clearly relates to a change in senior management, which fits the category of Board/Management Information (MANG). The document length is short and focused solely on this personnel change, confirming it is not a full report or announcement of a report publication.
2026-03-13 English
Agreements
Capital/Financing Update Classification · 95% confidence The document is a detailed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, concerning a First Amendment to a Loan Agreement between the company and its wholly owned subsidiary. It includes specifics about the loan, conversion to equity, approvals by the Board and Shareholders, and related party transaction details. The content focuses on a material related party transaction and amendment to a loan agreement, which is a capital/financing update rather than a full financial report, earnings release, or management discussion. The document is not an announcement of a report publication but a substantive disclosure about financing activity. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2026-02-23 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.